Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

629
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
629
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

668
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
668
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

851
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
851
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

967
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
967
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

319
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
319
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

317
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
317

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal function outcomes following endoscopic management of upper tract urothelial carcinoma.

World journal of urology·2026
Same author

Patterns of adjuvant intracavitary instillation and recurrence after endoscopic management of upper tract urothelial carcinoma.

World journal of urology·2026
Same author

Trends in Antibiotic Use for Kidney Stone Patients Discharged from United States Emergency Departments.

Journal of endourology·2026
Same author

Diagnostic Imaging for Suspected Nephrolithiasis in United States Emergency Departments.

Urology practice·2025
Same author

Associations between ureteral stent indwelling time, patient characteristics, and stent pain from an international prospective registry.

The Canadian journal of urology·2025
Same author

Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysis.

Urologic oncology·2025

Related Experiment Video

Updated: Mar 26, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

4.1K

Metabolic syndrome and nephrolithiasis.

Krishna Ramaswamy1, Ojas Shah1

  • 1New York University, New York, NY 10016, USA.

Translational Andrology and Urology
|January 28, 2016
PubMed
Summary

Metabolic syndrome (MS) significantly increases the risk of developing kidney stones (nephrolithiasis). Individuals with multiple MS traits face the highest incidence, suggesting complex underlying mechanisms. Further research is needed.

Keywords:
Atherosclerosiscardiovascular disease (CV disease)metabolic syndrome (MS)nephrolithiasisoxidative stress (OS)

More Related Videos

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.5K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

12.4K

Related Experiment Videos

Last Updated: Mar 26, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

4.1K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.5K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

12.4K

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Metabolic syndrome (MS) is a cluster of risk factors including hypertension, diabetes mellitus, and atherosclerosis.
  • Nephrolithiasis, or kidney stone disease, is increasingly recognized as being associated with systemic diseases.
  • The prevalence of kidney stones is rising, particularly in individuals with MS.

Purpose of the Study:

  • To review the association between metabolic syndrome and nephrolithiasis.
  • To explore the increased risk of kidney stone formation in individuals with MS traits.

Main Methods:

  • Literature review focusing on the relationship between MS and nephrolithiasis.
  • Analysis of existing studies on systemic diseases and kidney stone incidence.

Main Results:

  • Nephrolithiasis is disproportionately prevalent in individuals with MS.
  • The risk of kidney stone formation is elevated in those with cardiovascular disease, hypertension, and diabetes mellitus.
  • Individuals with multiple components of MS exhibit the highest incidence of kidney stones.

Conclusions:

  • A common underlying mechanism, potentially systemic inflammation and tissue damage, may link MS and nephrolithiasis.
  • The exact pathophysiological explanations for the increased stone risk in MS are complex and require further investigation.
  • Future research should explore mechanisms beyond population-based and urine physiochemical studies to understand the individual disease states.